Mr. Claes Ellegaard reports

SOLARVEST BIOENERGY INC. GRANTED PATENT IN BRAZIL

Solarvest Bioenergy Inc. has been granted a patent for organic omega-3 in Brazil. The intellectual property protection concentrates on the production of algal biomass, algal cell cultures, lipid compounds and compositions thereof, including fatty acids, carotenoids and fat-soluble vitamins. This patent adds additional strength to the company's existing patent portfolio as it commercializes its line of organic omega-3 products. Brazil is the largest country in South America with a population exceeding 217 million -- the seventh most populous country in the world.

The company is focused on supplying unique clean-label products to satisfy the demand for premium plant-based, organic omega-3 health products. In addition, the company's wholly owned subsidiary Eversea has accelerated efforts to offer organic marketing companies and organic-oriented retailers with house-branded products based on the company's unique bioavailable omega-3 ingredient. Channel marketing feedback indicates that there is extensive market demand for the product's unique characteristics, particularly among consumers focused on organic, vegetarian and vegan diets. The company's patented omega-3 products have obtained Food and Drug Administration NDI (new dietary ingredient) certification, and certified organic by the U.S. Department of Agriculture and European Union.

Further to this patent the company has previously been issued organic omega-3 patents in Japan, Australia and India. In addition, the patent is pending in practically every commercially significant global market, including the United States and the EU.

About Solarvest Bioenergy Inc.

Solarvest is an algae biologics company whose production platform provides it with an extremely flexible system capable of producing numerous products from omega-3 fatty acids to human therapeutic proteins.

We seek Safe Harbor.